About ZJ-IPS
  • 6000 W Investment of 60 million yuan

  • 100 + More than 100 cooperative customers

  • 100 W+ Project value is over million

  Zhejiang IPS Pharmaceutical Technology Co., Ltd. is jointly established by Sino Harbour Holdings Group Limited, Irvine Pharmaceutical Services Inc. and Zhejiang University of Technology with a total investment of 60 million yuan. It is a professional third-party drug testing and R&D institution jointly established with Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals with the commitment to providing high-quality drug development services for pharmaceutical companies at home and abroad.
        With its high-quality R&D teams and advanced scientific research instruments, and abiding by the standards of cGMP and US FDA, ZJ-IPS strive to build an independent third-party Laboratory that provides pharmaceutical companies with technical services in compliance with China, the United States, the United Kingdom, Japan, the European Pharmacopoeia, American Chemical Society, and American Analytical Chemistry Association (ChP, USP, BP, JP, EP, ACS, AOAC) and customer-specified standards. Upholding the principles of objectiveness, fairness, independence and efficiency, we provide R&D outsourcing services including pharmaceutical analysis and testing, conformity testing, market entry testing, stability testing of APIs and preparations, compatibility studies of pharmaceuticals and packaging materials and quality consistency evaluation of generic drugs.


Sino Harbour

 Sino Harbour Holdings Group Limited (the “Group”), formerly named as Sino Harbour Property Group Limited, is a property developer focused on the second and third tier cities in the P.R.C., with its headquarter in Hong Kong. The Group’s parent company – Pan Hong Holdings Group Limited (SGX:P36) (“Pan Hong Group”) was listed on Singapore Stock Exchange in 2006 and has more than 20 years of property development experience in niche markets in China. Pan Hong Group spun off the Group in 2011 to further expand its business. While the Group is currently principally engaged in the business of property development, it has been exploring and seeking new opportunities to broaden revenue stream and improve profitability. To better reflect the business nature and principal activities of the Group, the Group changed its name to Sino Harbour Holdings Group Limited from Sino Harbour Property Group Limited with effect from 24th August 2015 and began to enter into the pharmaceutical and healthcare industries. Since the change of name, the Group has founded several important subsidiaries including Sino Harbour Bio Technology Limited (“SH BioTech HK”), Jiangxi Sino Harbour Bio Technology Limited, Zhejiang Sino Harbour Bio Technology Limited and Guangxi Guarantee Bio Technology Limited

Irvine Pharmaceutical Services Co.,Ltd.

Irvine Pharmaceutical Services Co., Ltd was founded in 1988, and is based in Irvine California. IPS is a premier contract development and manufacturing organization, which has passed US FDA audit multiple times and has been providing technical support to the pharmaceutical, biopharmaceutical, and medical device industries for over 30 years. it provides full cGMP specialized product development service such as analytical testing, R&D, registration and declaration. At the same time, it has been widely recognized by the US FDA and USP and has participated in the calibration work of the United States Pharmacopoeia standard products. IPS has gained its status in the industry in the United States and has served 18 of the world’s top 20 pharmaceutical companies (e.g. Pfizer, Novartis)

Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals
It is one of the 14 collaborative innovation centers approved by the Ministry of Education and the Ministry of Finance under the "2011 Plan". The center was led by Zhejiang University of Technology, and was jointly established by Zhejiang University, Shanghai Institute of Pharmaceutical Industry, National Engineering Research Center for Pharmaceutical Preparations, Zhejiang Academy of Medical Sciences, and Zhejiang Food and Drug Inspection Institute. Its dedicated to cultivate top-notch innovative talents, services, universities, research institutes, companies, and international innovation agencies that lead the transformation and upgrade of the pharmaceutical industry.